Exploration of Clinical Breakpoint of Danofloxacin for <i>Glaesserella parasuis</i> in Plasma and in PELF

• Main Authors: Zihui Xu (Author), Anxiong Huang (Author), Xun Luo (Author), Peng Zhang (Author), Lingli Huang (Author), Xu Wang (Author), Kun Mi (Author), Shiwei Fang (Author), Xiao Huang (Author), Jun Li (Author), Zonghui Yuan (Author), Haihong Hao (Author)
• Format: Book
• Published: MDPI AG, 2021-07-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

<b>Background:</b> In order to establish the clinical breakpoint (CBP) of danofloxacin against <i>G. parasuis</i>, three cutoff values, including epidemiological cutoff value (ECV), pharmacokinetic-pharmacodynamic (PK-PD) cutoff value (CO_PD) and clinica...